Literature DB >> 25170260

Use of atypical antipsychotics in the elderly: a clinical review.

Pietro Gareri1, Cristina Segura-García2, Valeria Graziella Laura Manfredi1, Antonella Bruni2, Paola Ciambrone2, Gregorio Cerminara2, Giovambattista De Sarro2, Pasquale De Fazio2.   

Abstract

The use of atypical antipsychotic drugs in the elderly has become wider and wider in recent years; in fact, these agents have novel receptor binding profiles, good efficacy with regard to negative symptoms, and reduced extrapyramidal symptoms. However, in recent years, the use of both conventional and atypical antipsychotics has been widely debated for concerns about their safety in elderly patients affected with dementia and the possible risks for stroke and sudden death. A MEDLINE search was made using the words elderly, atypical antipsychotics, use, schizophrenia, psychosis, mood disorders, dementia, behavioral disorders, and adverse events. Some personal studies were also considered. This paper reports the receptor binding profiles and the main mechanism of action of these drugs, together with their main use in psychiatry and the possible adverse events in elderly people.

Entities:  

Keywords:  atypical antipsychotics; dementia; elderly; mood disorders; psychosis; side effects

Mesh:

Substances:

Year:  2014        PMID: 25170260      PMCID: PMC4144926          DOI: 10.2147/CIA.S63942

Source DB:  PubMed          Journal:  Clin Interv Aging        ISSN: 1176-9092            Impact factor:   4.458


  76 in total

1.  Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.

Authors:  I R Katz; D V Jeste; J E Mintzer; C Clyde; J Napolitano; M Brecher
Journal:  J Clin Psychiatry       Date:  1999-02       Impact factor: 4.384

2.  Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease.

Authors:  William G Ondo; Ron Tintner; Kevin Dat Voung; Dejian Lai; George Ringholz
Journal:  Mov Disord       Date:  2005-08       Impact factor: 10.338

3.  Ziprasidone attenuates brain injury after focal cerebral ischemia induced by middle cerebral artery occlusion in rats.

Authors:  Kyung-Yoon Kam; Angela M Anthony Jalin; Yong Won Choi; Phatcharida Kaengkan; Sung Woo Park; Young Hoon Kim; Sung Goo Kang
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-05-21       Impact factor: 5.067

Review 4.  Focus on quetiapine.

Authors:  B Green
Journal:  Curr Med Res Opin       Date:  1999       Impact factor: 2.580

5.  Olanzapine use in the elderly: a retrospective analysis.

Authors:  K Solomons; O Geiger
Journal:  Can J Psychiatry       Date:  2000-03       Impact factor: 4.356

6.  Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.

Authors:  Cheryl L P Vigen; Wendy J Mack; Richard S E Keefe; Mary Sano; David L Sultzer; T Scott Stroup; Karen S Dagerman; John K Hsiao; Barry D Lebowitz; Constantine G Lyketsos; Pierre N Tariot; Ling Zheng; Lon S Schneider
Journal:  Am J Psychiatry       Date:  2011-05-15       Impact factor: 18.112

Review 7.  Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.

Authors:  A H Glassman; J T Bigger
Journal:  Am J Psychiatry       Date:  2001-11       Impact factor: 18.112

8.  Olanzapine for psychosis in patients with Parkinson's disease with and without dementia.

Authors:  D Aarsland; J P Larsen; N G Lim; E Tandberg
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1999       Impact factor: 2.198

9.  A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD).

Authors:  Barnett S Meyers; Alastair J Flint; Anthony J Rothschild; Benoit H Mulsant; Ellen M Whyte; Catherine Peasley-Miklus; Eros Papademetriou; Andrew C Leon; Moonseong Heo
Journal:  Arch Gen Psychiatry       Date:  2009-08

Review 10.  Thrombotic complications of treatment with antipsychotic drugs.

Authors:  M Shulman; I Jennifer Njoku; P Manu
Journal:  Minerva Med       Date:  2013-04       Impact factor: 4.806

View more
  36 in total

1.  Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report.

Authors:  Thitiporn Supasitthumrong; Blanca M Bolea-Alamanac; Selim Asmer; Vincent L Woo; Petal S Abdool; Simon J C Davies
Journal:  Br J Clin Pharmacol       Date:  2019-02-08       Impact factor: 4.335

2.  Endocrine disruption as an adverse effect of non-endocrine targeting pharmaceuticals.

Authors:  Shakila Sabir; Muhammad Furqan Akhtar; Ammara Saleem
Journal:  Environ Sci Pollut Res Int       Date:  2018-11-22       Impact factor: 4.223

Review 3. 

Authors:  Linda Lee; Tejal Patel; Frank Molnar; Dallas Seitz
Journal:  Can Fam Physician       Date:  2018-09       Impact factor: 3.275

Review 4.  Optimizing medications in older adults with cognitive impairment: Considerations for primary care clinicians.

Authors:  Linda Lee; Tejal Patel; Frank Molnar; Dallas Seitz
Journal:  Can Fam Physician       Date:  2018-09       Impact factor: 3.275

5.  Histone deacetylase inhibitors reverse age-related increases in side effects of haloperidol in mice.

Authors:  Janitza L Montalvo-Ortiz; Daniel W Fisher; Guadalupe Rodríguez; Deyu Fang; John G Csernansky; Hongxin Dong
Journal:  Psychopharmacology (Berl)       Date:  2017-04-18       Impact factor: 4.530

Review 6.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

7.  Elderly patients treated with psychotropic medicines admitted to hospital: associated characteristics and inappropriate use.

Authors:  Xavier Vidal; Antonia Agustí; Antoni Vallano; Francesc Formiga; Antonio Fernández Moyano; Juana García; Alfonso López-Soto; Nieves Ramírez-Duque; Olga H Torres; José Barbé; Antonio San-José
Journal:  Eur J Clin Pharmacol       Date:  2016-03-05       Impact factor: 2.953

Review 8.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly.

Authors:  Glenda M MacQueen; Benicio N Frey; Zahinoor Ismail; Natalia Jaworska; Meir Steiner; Ryan J Van Lieshout; Sidney H Kennedy; Raymond W Lam; Roumen V Milev; Sagar V Parikh; Arun V Ravindran
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

9.  Perioperative Gabapentin Does Not Reduce Postoperative Delirium in Older Surgical Patients: A Randomized Clinical Trial.

Authors:  Jacqueline M Leung; Laura P Sands; Ningning Chen; Christopher Ames; Sigurd Berven; Kevin Bozic; Shane Burch; Dean Chou; Kenneth Covinsky; Vedat Deviren; Sakura Kinjo; Joel H Kramer; Michael Ries; Bobby Tay; Thomas Vail; Philip Weinstein; Stacey Chang; Gabriela Meckler; Stacey Newman; Tiffany Tsai; Vanessa Voss; Emily Youngblom
Journal:  Anesthesiology       Date:  2017-10       Impact factor: 7.892

10.  Epigenetic Alterations Impact on Antipsychotic Treatment in Elderly Patients.

Authors:  Bryan M McClarty; Daniel W Fisher; Hongxin Dong
Journal:  Curr Treat Options Psychiatry       Date:  2018-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.